A total of 1,091 patients with type 2 diabetes and HbA 1c levels of 7.5–11.0% were randomly assigned to receive combination therapy with daily sitagliptin (100 mg) and metformin (either 1,000 mg ...
The combination of sitagliptin and metformin provided a more than additive effect on native GLP-1 concentrations. This combination may benefit patients with Type 2 diabetes through substantial ...
Compared with currently available insulin secretagogues, DPP-4 inhibitors, by enhancing biologically active (intact) GLP-1, increase ... daily dose of sitagliptin 100 mg and metformin 2000 mg.
Concentrate for solution for infusion (25 mg/1.25 mL, 20 mg/mL). For diabetes: • Sitagliptin: Film-coated tablet (25 mg, 50 mg, 100 mg). • Sitagliptin (as hydrochloride) + Metformin ...